AustralieFrV1, PubMed, Corpus, bibRecord, 001388

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.

Identifieur interne : 001388 ( PubMed/Corpus ); précédent : 001387; suivant : 001389

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.

Auteurs : Bastian Von Tresckow ; Franck Morschhauser ; Jeffrey Szer ; Dennis A. Eichenauer ; Jeremy S. Abramson ; Anna Sureda ; Andreas Engert

Source :

Leukemia & lymphoma [ 1029-2403 ] ; 2017.

RBID : pubmed:27184350
DOI: 10.1080/10428194.2016.1182164
PubMed: 27184350

Links to Exploration step

pubmed:27184350

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.</title>
<author><name sortKey="Von Tresckow, Bastian" sort="Von Tresckow, Bastian" uniqKey="Von Tresckow B" first="Bastian" last="Von Tresckow">Bastian Von Tresckow</name>
<affiliation><nlm:affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Morschhauser, Franck" sort="Morschhauser, Franck" uniqKey="Morschhauser F" first="Franck" last="Morschhauser">Franck Morschhauser</name>
<affiliation><nlm:affiliation>b Hematology Department , CHRU Lille Hopital Claude Huriez , Lille , France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Szer, Jeffrey" sort="Szer, Jeffrey" uniqKey="Szer J" first="Jeffrey" last="Szer">Jeffrey Szer</name>
<affiliation><nlm:affiliation>c Bone Marrow Transplant Unit , Royal Melbourne Hospital , Parkville , VIC , Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Eichenauer, Dennis A" sort="Eichenauer, Dennis A" uniqKey="Eichenauer D" first="Dennis A" last="Eichenauer">Dennis A. Eichenauer</name>
<affiliation><nlm:affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Abramson, Jeremy S" sort="Abramson, Jeremy S" uniqKey="Abramson J" first="Jeremy S" last="Abramson">Jeremy S. Abramson</name>
<affiliation><nlm:affiliation>d Massachusetts General Hospital, Yawkey Center , Suite 9A , Boston , MA , USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sureda, Anna" sort="Sureda, Anna" uniqKey="Sureda A" first="Anna" last="Sureda">Anna Sureda</name>
<affiliation><nlm:affiliation>e Hematology Department , Hospital De La Santa Creu I Sant Pau, Mas Casanovas , Barcelona , Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Engert, Andreas" sort="Engert, Andreas" uniqKey="Engert A" first="Andreas" last="Engert">Andreas Engert</name>
<affiliation><nlm:affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27184350</idno>
<idno type="pmid">27184350</idno>
<idno type="doi">10.1080/10428194.2016.1182164</idno>
<idno type="wicri:Area/PubMed/Corpus">001388</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001388</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.</title>
<author><name sortKey="Von Tresckow, Bastian" sort="Von Tresckow, Bastian" uniqKey="Von Tresckow B" first="Bastian" last="Von Tresckow">Bastian Von Tresckow</name>
<affiliation><nlm:affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Morschhauser, Franck" sort="Morschhauser, Franck" uniqKey="Morschhauser F" first="Franck" last="Morschhauser">Franck Morschhauser</name>
<affiliation><nlm:affiliation>b Hematology Department , CHRU Lille Hopital Claude Huriez , Lille , France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Szer, Jeffrey" sort="Szer, Jeffrey" uniqKey="Szer J" first="Jeffrey" last="Szer">Jeffrey Szer</name>
<affiliation><nlm:affiliation>c Bone Marrow Transplant Unit , Royal Melbourne Hospital , Parkville , VIC , Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Eichenauer, Dennis A" sort="Eichenauer, Dennis A" uniqKey="Eichenauer D" first="Dennis A" last="Eichenauer">Dennis A. Eichenauer</name>
<affiliation><nlm:affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Abramson, Jeremy S" sort="Abramson, Jeremy S" uniqKey="Abramson J" first="Jeremy S" last="Abramson">Jeremy S. Abramson</name>
<affiliation><nlm:affiliation>d Massachusetts General Hospital, Yawkey Center , Suite 9A , Boston , MA , USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sureda, Anna" sort="Sureda, Anna" uniqKey="Sureda A" first="Anna" last="Sureda">Anna Sureda</name>
<affiliation><nlm:affiliation>e Hematology Department , Hospital De La Santa Creu I Sant Pau, Mas Casanovas , Barcelona , Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Engert, Andreas" sort="Engert, Andreas" uniqKey="Engert A" first="Andreas" last="Engert">Andreas Engert</name>
<affiliation><nlm:affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Leukemia & lymphoma</title>
<idno type="eISSN">1029-2403</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">27184350</PMID>
<DateCreated><Year>2016</Year>
<Month>05</Month>
<Day>17</Day>
</DateCreated>
<DateRevised><Year>2016</Year>
<Month>11</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1029-2403</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>58</Volume>
<Issue>1</Issue>
<PubDate><Year>2017</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Leukemia & lymphoma</Title>
<ISOAbbreviation>Leuk. Lymphoma</ISOAbbreviation>
</Journal>
<ArticleTitle>Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.</ArticleTitle>
<Pagination><MedlinePgn>222-225</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>von Tresckow</LastName>
<ForeName>Bastian</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Morschhauser</LastName>
<ForeName>Franck</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>b Hematology Department , CHRU Lille Hopital Claude Huriez , Lille , France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Szer</LastName>
<ForeName>Jeffrey</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>c Bone Marrow Transplant Unit , Royal Melbourne Hospital , Parkville , VIC , Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Eichenauer</LastName>
<ForeName>Dennis A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo><Affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Abramson</LastName>
<ForeName>Jeremy S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo><Affiliation>d Massachusetts General Hospital, Yawkey Center , Suite 9A , Boston , MA , USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sureda</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>e Hematology Department , Hospital De La Santa Creu I Sant Pau, Mas Casanovas , Barcelona , Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>f Hematology Department , Institut Català D'Oncologia - L'Hospitalet , Gran via , Barcelona , Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Engert</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>05</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Leuk Lymphoma</MedlineTA>
<NlmUniqueID>9007422</NlmUniqueID>
<ISSNLinking>1026-8022</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27184350</ArticleId>
<ArticleId IdType="doi">10.1080/10428194.2016.1182164</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001388 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001388 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:27184350
   |texte=   Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:27184350" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki